Research and Markets: Antibody Target, Technology & Pipeline Database - Online Access To Information About More Than 2,400 Project Entries

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/lp5dxb/antibody_target) has announced the addition of the "Antibody Target, Technology & Pipeline Database: 1-Year Subscription" subscription to their offering.

Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about more than 2,400 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their

- Technology (e.g. antibody-drug conjugate, bispecific, isotype, phage display)

- Target (e.g. Her2, CD20, TNF, PD-1/PD-L1)

- Pipelines (selected by target, therapeutic area, company, technology)

- Sales (for marketed antibodies)

- R&D Phase (clinical phases, market, preclinical)

- Territory (countrywise)

- Therapeutic Area (e.g. infectious, oncology, gastrointestinal)

- Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antidoies on the market are provided. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.

Special Focus of the Database

- Antibody-Drug Conjugates

- Bispecific Antibodies

- Biosimilar and Biosuperior Antibodies

Reasons To Buy

- Intuitive use

- Designed for structured searches

- Focused on targets, therapeutic areas and R&D phases

- Ideal for competitor analysis (companies, targets, technologies, R&D phase)

- Cost-effective and rapid solution for benchmarking

- Identification of licensing candidates

Project listing in a tabular format

- Drug Codes

- Target

- Class of Compound

- Company

- Territory

- Therapeutic Area

- Indication

- R&D Phase

Therapeutic Areas

- Cardiovascular & blood

- Dermatology

- Gastrointestinal

- Genitourinary, renal & gynecology

- Infectious & toxicology

- Metabolism & endocrine

- Neurology & psychiatry

- Oncology

- Ophthalmology & otorhinolaryngology

- Orthopedics, dental, anesthesia & surgery

- Pulmonary & respiratory

- Rheumatoid & autoimmune

For more information visit http://www.researchandmarkets.com/research/lp5dxb/antibody_target

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals